Suport vital bàsic pediàtric 2021

El suport vital bàsic pediàtric (SVBP), abans RCP bàsica pediàtrica (RCPBP), és una de les anelles en la cadena de supervivència de l'infant en aturada cardiorespiratòria (ACR) 1. La seva importància ve donada pel paper clau que té en l'atenció immediata a l'emergència i perquè és un element essencial de suport a la reanimació avançada. Les principals novetats en les recomanacions en SVBP fetes per l'ERC (Consell Europeu de Ressuscitació) els anys 2005, 2010 i 2015 han estat difoses pel Comitè d'RCP de la Societat Catalana de Pediatria (CRCPSCP) a través de Pediatria Catalana 2-4. En aquest article es presenten els aspectes que representen una novetat o que són particularment rellevants de les noves guies 2021 de l'ERC pel que fa al SVBP Cal recordar que l'ús del desfibril·lador extern automatitzat (DEA) i l'atenció a l'obstrucció de la via aèria per cos estrany (OVACE) són part integral del SVBP

Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study

Objective: To investigate the relationship between length of hospitalisation (LOH) and post-discharge outcomes in acute heart failure (AHF) patients and to ascertain whether there are different patterns according to department of initial hospitalisation. Methods: Consecutive AHF patients hospitalised in 41 Spanish centres were grouped based on the LOH (15 days). Outcomes were defined as 90-day post-discharge all-cause mortality, AHF readmissions, and the combination of both. Hazard ratios (HRs), adjusted by chronic conditions and severity of decompensation, were calculated for groups with LOH >6 days vs. LOH <6 days (reference), and stratified by hospitalisation in cardiology, internal medicine, geriatrics, or short-stay units. Results: We included 8563 patients (mean age: 80 (SD = 10) years, 55.5% women), with a median LOH of 7 days (IQR 4–11): 2934 (34.3%) had a LOH 15 days. The 90-day post-discharge mortality was 11.4%, readmission 32.2%, and combined endpoint 37.4%. Mortality was increased by 36.5% (95%CI = 13.0–64.9) when LOH was 11–15 days, and by 72.0% (95%CI = 42.6–107.5) when >15 days. Conversely, no differences were found in readmission risk, and the combined endpoint only increased 21.6% (95%CI = 8.4–36.4) for LOH >15 days. Stratified analysis by hospitalisation departments rendered similar post-discharge outcomes, with all exhibiting increased mortality for LOH >15 days and no significant increments in readmission risk. Conclusions: Short hospitalisations are not associated with worse outcomes. While post-discharge readmissions are not affected by LOH, mortality risk increases as the LOH lengthens. These findings were similar across hospitalisation departments